Early identification of toxic liabilities is essential for improving drug safety and reducing attrition. However, structure-based deep learning models often generalize poorly to new chemical scaffolds and provide limited biological mechanistic insight. To address this, we introduce Toxicological Knowledge-guided Graph-...
Yanjing Duan, Woruo Chen, Kun Li et al.· Journal of Medicinal Chemist...· 0 citations
INTRODUCTION
Poly(ADP-ribose) polymerase 1 (PARP1) is a key mediator of DNA damage repair and an attractive therapeutic target for homologous recombination-deficient malignancies. The development of selective PARP1 inhibitors has been driven by the need to reduce the hematological toxicities associated with nonselectiv...
Jilong Duan, Yanjing Duan, Dongling Gu et al.· Expert Opinion on Therapeuti...· 0 citations
By delineating how physics-based priors synergize with data-driven representation learning, this review provides a comprehensive roadmap for generating physically plausible and thermodynamically stable therapeutics, ultimately accelerating the transition of computationally designed molecules from in silico blueprints t...
Hao-Bo Xie, Hao Wang, Xiao-Jun Yao et al.· The Innovation Drug Discover...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.